An Indian court petition is challenging public-health authorities to demonstrate the scientific foundations of germ theory, prompting a dispute over evidence and the limits of judicial intervention. New Zealand researchers have reportedly joined the proceedings, bringing the case into a wider international debate about scientific accountability
Report by eLocal
An unusual legal challenge in India has attracted international attention after a petitioner asked the courts to compel public-health authorities to demonstrate the scientific evidence supporting viruses, germ theory and immunisation. The proceedings have become the subject of a new video presentation by New Zealand medical commentator Dr Sam Bailey below, who argues that the government's response raises fundamental questions about scientific evidence and public accountability.
The case raises two distinct issues. The first concerns whether public-health institutions should be required to produce scientific evidence when their policies are challenged. The second concerns whether the petitioner's scientific objections are themselves supported by the available evidence. Both questions matter, but they should not be confused: a court's decision about whether a petition is legally maintainable does not, by itself, determine whether a scientific theory is correct.
In her September 2026 presentation, Bailey examines what she describes as a formal response from the Indian state of Chhattisgarh. She reports that the petitioner has received a reply after months of delay and that international supporters, including herself, have become involved.
The account is based principally on Bailey's video and its supplied transcript. The underlying petition, complete government response and court docket have not been independently authenticated for this report. Consequently, the reported procedural developments and quotations from the response remain attributed to the presentation.
The Petition and Its Demands
According to Bailey, the proceedings began in February 2026 when Jatendra Banjara, whom she describes as having postgraduate training in medical microbiology, filed a public-interest petition seeking scientific demonstrations of the existence of viruses and evidence supporting germ theory.
The respondents reportedly include the Union of India, the Indian Council of Medical Research, the National Institute of Virology and the National Centre for Disease Control.
The petition goes considerably further than requesting access to scientific publications. As described in the video, it asks the court to direct public-health authorities to conduct practical demonstrations concerning disease-causing microorganisms, immunity and immunisation. It also seeks the shutdown of medical microbiology in the absence of what the petitioner considers satisfactory proof.
These demands create a significant legal distinction. Requesting access to government-held evidence is different from asking a court to compel scientists to perform experiments under conditions selected by a litigant. The latter raises questions about judicial authority, laboratory procedures, research ethics and the appropriate standards for assessing scientific evidence.
Bailey reports that the court initially allowed the government respondents four weeks to submit replies. She says a response from Chhattisgarh arrived in early September, approximately six months after the original proceedings began.
The reported delay deserves clarification through the court record, particularly whether the original direction applied to every respondent, whether extensions were granted and which parties have filed their responses.
The Government's Response
Bailey's presentation concentrates on several passages attributed to Chhattisgarh's preliminary submissions.
According to the video, the state questions the petitioner's expertise and argues that the dispute involves specialised scientific and public-health matters requiring consideration of established expert institutions.
Bailey challenges the reported description of the petitioner as "only a microbiologist", arguing that his scientific training is directly relevant to the subject of the proceedings. She also objects to the state's reported reliance on established medical authorities, characterising it as an appeal to authority rather than a substantive response to the petition.
The distinction between expertise and evidence is important. Scientific qualifications can help establish whether someone is equipped to assess a particular subject, but neither credentials nor institutional standing make an individual's claims automatically correct. Scientific conclusions must ultimately be assessed through methods, observations, reproducibility and the strength of the available evidence.
However, a government's decision to contest a petition on procedural or legal grounds is not equivalent to admitting that it lacks scientific evidence. The complete submissions and any subsequent court findings are needed to establish precisely what the government has argued and how the court has responded.
Koch's Postulates and the Scientific Dispute
A central element of Bailey's criticism concerns the government's reported reliance on Koch's postulates, the nineteenth-century criteria developed to investigate whether particular microorganisms cause particular diseases.
Bailey argues that the original postulates have not been satisfied and questions the use of molecular techniques, including polymerase chain reaction (PCR), as evidence of viral infection. She maintains that detecting genetic sequences cannot establish the existence of a virus unless the virus has first been independently demonstrated.
This is where the petition's scientific claims require careful examination.
Koch's original postulates were developed primarily in the context of bacterial disease. Viruses differ from bacteria because they require living host cells to reproduce. The original requirement for growth in pure culture therefore cannot be applied to viruses in precisely the same manner.
Scientists have recognised these limitations for decades and developed additional approaches to investigating infectious disease, including cell culture, electron microscopy, molecular sequencing, immunological studies and experimental research.
Published research documents the isolation and identification of viruses through multiple complementary methods. A study published in the CDC's Emerging Infectious Diseases journal, for example, describes how cell culture and electron microscopy contributed to identifying viruses associated with previously unexplained disease outbreaks.
Cell Culture and Electron Microscopy for Identifying Viruses
A 1996 review in Clinical Microbiology Reviews also examines how Koch's original criteria have been adapted to incorporate molecular evidence and the difficulties involved in establishing causation.
Sequence-Based Identification of Microbial Pathogens
These findings establish that the broader assertion that viruses have never been demonstrated is inconsistent with published experimental evidence. They do not mean that every proposed association between a newly identified virus and a particular illness is automatically proven.
Indeed, virologists themselves recognise that detecting a virus in a patient does not necessarily establish that it caused the patient's symptoms. Establishing causation can require several independent lines of evidence, particularly where asymptomatic infections and other contributing factors are involved.
This distinction deserves greater attention because it separates legitimate questions about the interpretation of diagnostic tests from the substantially broader claim that viruses do not exist.
Clinical Trials and Public-Health Accountability
Bailey also challenges statements she attributes to the government's response concerning pharmaceutical regulation and clinical trials.
According to her presentation, the state argues that drug and vaccine approval procedures provide empirical evidence supporting medical interventions. Bailey questions whether the available clinical-trial evidence adequately establishes vaccine safety and effectiveness, particularly when measured against placebo-controlled outcomes and overall mortality.
There are several separate questions here. Whether a particular vaccine prevents infection, reduces severe disease, affects transmission or changes overall mortality depends on the product, disease, study design and population examined. Evidence supporting one outcome cannot automatically be substituted for evidence supporting another.
Likewise, the existence of pharmaceutical legislation establishes a regulatory framework, not the scientific effectiveness of every product approved under it.
The appropriate public-interest test is whether regulators accurately describe the evidence supporting each intervention, acknowledge its limitations and provide accessible explanations of their decisions.
An investigation of the government's reported clinical-trial claims would therefore require the complete submission and the particular products and studies to which it refers. The video does not establish that the official responsible for the response committed perjury, as Bailey suggests.
International Participation
Bailey concludes her presentation by announcing that she, Dr Mark Bailey and Canadian researcher Christine Massey have formally joined the Indian initiative.
She says the group intends to support Banjara's challenge and dispute the government's reported objections to the petitioner's scientific credentials.
Massey is known for submitting information requests to health and research institutions concerning records of virus isolation. Bailey argues that the responses support her position that the conventional virus model lacks scientific foundations.
However, an institution's response to a request framed around a particular definition of isolation is not equivalent to a comprehensive assessment of all published virological evidence. The wording and scope of individual requests, the records held by the responding institution and the scientific methods being discussed must all be examined before drawing broader conclusions.
The reported international participation nevertheless introduces an additional dimension to the proceedings. The dispute now involves individuals outside India who are seeking to challenge established scientific and public-health institutions through the courts.
Their precise legal standing and the nature of their participation remain to be established from the official case documents.
Does This Affect New Zealand?
The Indian proceedings raise questions that extend beyond the specific scientific claims advanced by the petitioner.
New Zealand's experience during the COVID-19 pandemic demonstrated the considerable influence that scientific advice and public-health institutions can exercise over government decisions affecting employment, business activity, personal movement and individual medical choices.
Those decisions involved complex assessments of scientific evidence, public-health risks, legal powers and competing individual interests.
The resulting public debate exposed an enduring question about accountability: how should citizens obtain meaningful scrutiny of scientific evidence when that evidence forms the basis for consequential government restrictions?
The answer requires more than institutional assurances. Public-health authorities should be able to explain the evidence supporting their recommendations, distinguish established findings from uncertainty and demonstrate how changing evidence influences policy.
Equally, meaningful scrutiny requires applying the same evidentiary standards to critics. An unanswered information request, an unsuccessful legal argument or a disputed interpretation of a laboratory method cannot independently overturn an extensive body of experimental research.
The Indian petition provides an opportunity to examine both sides of that accountability question.
For New Zealanders, its significance will depend partly on what the Indian court actually decides. A procedural dismissal would not settle the scientific issues, while an order requiring further disclosure would not establish that the petitioner's scientific conclusions were correct.
The more consequential outcome may be whether the proceedings produce a transparent record of the evidence submitted, the government's arguments and the court's reasoning.
Evidence, Authority and Public Trust
The distinction between scientific evidence and institutional authority sits at the centre of this controversy.
Bailey's presentation raises questions about the government's reported response, particularly its treatment of the petitioner's qualifications, reliance on expert institutions and objections to the requested laboratory demonstrations.
However, the broader claim that germ theory and the existence of viruses lack scientific foundations is contradicted by substantial published experimental research.
These two observations can coexist. Government institutions should be accountable for their scientific claims, while challenges to those claims must themselves withstand scientific scrutiny.
For the Indian proceedings, the next essential documents are the authenticated petition, the complete government submissions and the court's subsequent orders.
Until those records are available, the case should be understood as a reported legal challenge involving disputed scientific assertions, not as a judicial finding that germ theory has been disproven.
The central public-interest principle is straightforward: scientific claims should be open to examination, and the same standard of evidence should apply regardless of who advances them.
Sources
Publication verification note: The original Indian court filings and case number have not been independently confirmed. Direct quotations and procedural claims attributed to the government require checking against authenticated court documents before publication.